Onconetix (: ONCO) surged 8.98% in pre-market trading on Wednesday, July 16, 2025, reaching $4.94, up from the previous closing price of $4.53.
The jump follows the announcement of a definitive merger agreement with Ocuvex Therapeutics, Inc., under which Onconetix will acquire all outstanding equity interests of Ocuvex. The transaction, expected to close in the fourth quarter, will expand Onconetix’s board of directors to seven members, with five appointed by Ocuvex and two by Onconetix.
